SCHEMBL5024415

SCHEMBL5024415

NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccc(C(F)(F)F)cc1)C(=O)Nc1cnc2ccccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 2/20 0.48
HDAC1 Q13547 8/20 0.47
HDAC4 P56524 5/20 0.47
HDAC3 O15379 4/20 0.46
HDAC7 Q8WUI4 4/20 0.46
HDAC2 Q92769 4/20 0.46
HDAC10 Q969S8 4/20 0.46
HDAC11 Q96DB2 4/20 0.46
HDAC8 Q9BY41 4/20 0.46
HDAC6 Q9UBN7 4/20 0.46
HDAC9 Q9UKV0 4/20 0.46
HDAC5 Q9UQL6 4/20 0.46
CNR1 P21554 2/20 0.46
CNR2 P34972 2/20 0.46
BDKRB2 P30411 1/20 0.43
SCN9A Q15858 1/20 0.43
ADCY6 O43306 1/20 0.42
ADCY3 O60266 1/20 0.42
ADCY9 O60503 1/20 0.42
ADCY5 O95622 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1245446 0.90 BDKRB2 (0.46) MCHR1HDAC1HDAC4HDAC3HDAC7
SCHEMBL2749004 0.89 HDAC1 (0.64) MCHR1HDAC1HDAC4HDAC3HDAC7
SCHEMBL13365364 0.88 HDAC1 (0.46) MCHR1HDAC1HDAC4HDAC3HDAC7
SCHEMBL5018473 0.87 MCHR1 (0.45) MCHR1HDAC1HDAC4HDAC3HDAC7
SCHEMBL5026047 0.87 MCHR1 (0.45) MCHR1HDAC1HDAC4HDAC3HDAC7
SCHEMBL5018245 0.85 BDKRB2 (0.44) MCHR1HDAC1HDAC4HDAC3HDAC7
SCHEMBL1246469 0.84 MCHR1 (0.47) MCHR1HDAC1HDAC4HDAC3HDAC7
SCHEMBL10084249 0.84 HDAC1 (0.44) MCHR1HDAC1HDAC4HDAC3HDAC7
SCHEMBL12341538 0.84 HDAC1 (0.44) MCHR1HDAC1HDAC4HDAC3HDAC7
SCHEMBL14035985 0.84 BDKRB2 (0.44) MCHR1HDAC1HDAC4HDAC3HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178490-B2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof REMPEX PHARMACEUTICALS, INC. (US) 2012-05-15 US disclosed
US-20100152098-A1 POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF MPEX PHARMACEUTICALS, INC. (US) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152098-A1 POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF ABCB11, ABCB1, SLC47A1 MCHR1 4499/4885HDAC1 852/4885HDAC4 653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.